Using nonsense and deletion mutants of herpes simplex virus type 1, we investigated the roles of three immediate-early proteins (ICP4, ICP27 and ICPO) in the establishment and reactivation of ganglionic latency in a mouse ocular model. DNA hybridization, superinfection-rescue, and cocultivation techniques provided quantitative data that distinguished between the failure of a virus to establish latency in the ganglion and its failure to reactivate. Null mutants with lesions in the genes for ICP4 and ICP27 did not replicate in the eye or in ganglia and failed to establish reactivatable latent infections. Three ICPO deletion mutants which could replicate in the eye and ganglia varied in their ability to establish and reactivate from the latent state, demonstrating that ICPO plays a role both in the establishment and the reactivation of latency. During the initial replicative phase of infection, all, or nearly all, viral genes are expressed. The immediate-early (or a) genes of HSV-1 are expressed in the absence of prior viral protein synthesis, and their expression is required for the expression of the early (or ,B) and late (or y) classes of viral genes (5, 9, 15, 16, 36 (6, 8-10, 12, 23, 24, 31). Although ICPO is a potent trans-activator of all three classes of HSV-1 genes (immediate-early, early, and late) in transient expression assays and likely plays a major role at some point in the viral life cycle (10, 12, 24, 31, 40) , the gene for ICPO can be deleted with only minor effects on productive infection in cell culture (34, 40) . The observation that ICP4 can inhibit the activities of immediate-early HSV-1 promoters, whereas ICPO can induce these activities in transient expression assays, led O' Hare and Hayward (25) A major problem in previous studies of latency has been the inability to differentiate between the failure of a virus to establish latency and its failure to reactivate from the latent state. In the present study we define the establishment of latency by the demonstration of viral DNA in individual latently infected ganglia. Based on this definition, we used two approaches to examine and quantify levels of viral DNA in infected ganglia. The first approach is slot-blot hybridization, and the second involves superinfection of dissociated 759
Observations from animal models and clinical studies of herpes simplex virus type 1 (HSV-1) infections in humans have led to the classical theory of herpesvirus latency which describes the stages characteristic of this lifelong neurotropic infection (48) . Following entry into the host, virus undergoes primary replication in the skin or mucosae. The virus then gains access to the distal axon terminals of sensory neurons and travels by axonal transport to neuronal cell bodies in sensory ganglia, where limited replication may occur and viral gene expression is repressed, leading to the latent state. No free infectious virus can be detected in ganglia during latency, although the controls responsible for maintaining the latent state may break down such that infectious virus is again produced to initiate a reactivation event.
During the initial replicative phase of infection, all, or nearly all, viral genes are expressed. The immediate-early (or a) genes of HSV-1 are expressed in the absence of prior viral protein synthesis, and their expression is required for the expression of the early (or ,B) and late (or y) classes of viral genes (5, 9, 15, 16, 36) . By contrast, during latency in neurons, viral gene expression is almost completely repressed. HSV-1, therefore, exhibits two very different modes of gene expression during the acute and latent phases of its life cycle within the host. The mechanisms involved at the molecular level in the repression of viral gene expression during the establishment and maintenance of latency and the derepression of viral gene expression that signals reactivation are not understood.
To identify viral factors that play a role in the establishment and reactivation of latency, we focused on the immediate-early proteins of HSV-1. These proteins are the first to be synthesized in the viral replicative cycle and three of them (infected cell proteins [ICPs] ICP4, ICPO, and ICP27) have been shown to modulate gene expression during pro-* Corresponding author. ductive infection. ICP4 performs an essential role in virus replication (9, 28) and has at least two regulatory activities: the trans-activation of early and late gene expression and the repression of expression of ICP4 and possibly other immediate-early genes (6, 8-10, 12, 23, 24, 31) . Although ICPO is a potent trans-activator of all three classes of HSV-1 genes (immediate-early, early, and late) in transient expression assays and likely plays a major role at some point in the viral life cycle (10, 12, 24, 31, 40) , the gene for ICPO can be deleted with only minor effects on productive infection in cell culture (34, 40) . The observation that ICP4 can inhibit the activities of immediate-early HSV-1 promoters, whereas ICPO can induce these activities in transient expression assays, led O'Hare and Hayward (25) to propose that ICP4 and ICPO together may mediate the switch between the lytic and latent modes of infection. Studies of temperature-sensitive and deletion mutants in the gene for ICP27 have demonstrated that this protein, like ICP4, plays an essential role in virus replication (23a, 34) . In transient expression assays, ICP27 is able to further down-or upregulate the expression of specific early and late genes whose expression is induced by ICP4, ICPO, or both (11, 31a, 35a ; L. Su and D. M. Knipe, manuscript in preparation). The demonstrated roles of immediate-early proteins in the regulation of HSV-1 gene expression and the availability of a series of wellcharacterized nonsense and deletion mutants in the genes for these three proteins prompted the present investigation of their roles in latency.
A major problem in previous studies of latency has been the inability to differentiate between the failure of a virus to establish latency and its failure to reactivate from the latent state. In the present study we define the establishment of latency by the demonstration of viral DNA 
MATERIALS AND METHODS
Cells and viruses. African green monkey kidney (Vero), E5, 3-3, and 0-28 cells were propagated as described previously (33) . E5 cells, which express complementing levels of ICP4, were made from Vero cells as described previously (7) . Cell lines 3-3 and 0-28 were also derived from Vero cells and express complementing levels of ICP27 (23a) and ICPO (34) , respectively.
Procedures for the growth and assay of the KOS strain of HSV-1 have been described previously (35) . The ICP4 mutants AAT, n6, n12, and n18 were kindly provided by N. DeLuca (Dana-Farber Cancer Institute, Boston, Mass.) and propagated as described by DeLuca and Schaffer (7) . The ICP27 deletion mutant 5d11.2 was constructed and grown as described by McCarthy et al. (23a) . The origin and propagation of the two KOS ICPO deletion mutants dlx0.7 and dlx3.1 have been described elsewhere (34) . HSV-1 strain 17 and d1l403 were kindly provided by N. Stow and G. Clements (Medical Research Council Virology Unit, Glasgow, and University of Glasgow, Glasgow, Scotland) and have been described elsewhere (40) .
Animal procedures. Seven-week-old randomly bred CD-1 mice (Charles River Breeding Laboratories, Inc., Kingston, N.Y.) were anesthetized with sodium pentobarbital, their corneas were scarified, and 20 ,ul of virus at the appropriate concentration per eye was added as described previously (41) . At various times postinfection, both eyes of each mouse were swabbed with cotton, and swabs were suspended in 1 (40) . The nonsense mutant n6 specifies a peptide lacking the N-terminal 90 amino acids of ICP4; n12 and n18 specify peptides lacking the C-terminal three-quarters and one-third of the ICP4 peptide, respectively (8) (Fig. 4) . Both n6 and AAT, however, were reactivated from 10 of 12 the primary site of infection is important for the establishment of latency. ICPO is required for the efficient establishment and reactivation of latency. To assess the role of ICPO in latency, two ICPO deletion mutants, dlx3.1 and dlx0.7 (Fig. 3) , that are replication competent in cell culture yet that lack functional ICPO (as judged by transient expression assays [34] ) were tested in our latency model.
The two ICPO deletion mutants behaved similarly to each other during acute infection. They were both replication competent in the eye and in ganglia, although the levels of infectious virus were 10-to 100-fold lower than those of KOS in the eye and 1,000-fold lower than those of KOS in trigeminal ganglia (Fig. 4 and Table 1 cells. The inability of these mutants to reactivate could have been due either to the failure of mutant viral DNA to reach trigeminal ganglia or to the intrinsic properties of the mutants; i.e., they either failed to establish latency appropriately or they lacked the ability to reactivate. To distinguish between these possibilities, we determined whether individual ganglia from mice infected with dlx0.7 and dlx3.1 contained detectable viral DNA. We used both slot-blot hybridization and the superinfection assay to address this question. Viral DNA was readily detectable by slot-blot hybridization in ganglia from mice that were inoculated 30 days previously with dIx3.1 (Fig. 5) . These ganglia contained about 0.5 copy of viral DNA per cell compared with 0.5 to 1.0 copy per cell for KOS. Significantly, doses of KOS (2 x 104 to 2 x 105 PFU per eye) that yielded 0.5 copy of viral DNA per cell in ganglia (Fig. 2) yielded reactivatable latency in 75% of ganglia ( Fig. 1 ) compared with <2% for dlx3.1 (Fig. 4 and 5) . Thus, the failure of dlx3.1 to reactivate was not due simply to the absence of viral DNA in trigeminal ganglia.
We next used the superinfection assay to ascertain whether the viral DNA was in a biologically retrievable state. Ganglia from mice that were infected 30 days previously with dlx3.1 when dissociated and superinfected with 5d11.2 yielded virus in all cases tested (12 of 12), with a mean of 21 plaques produced from each ganglion ( Table 1) . Southern blot analysis of DNA from individual plaque isolates indicated the presence of both mutant and wild-type ICPO alleles, demonstrating that reactivated virus resulted from both complementation and recombination following superinfection (Fig. 6) . As controls in this study, mock-infected ganglia were infected with 5d11.2. These ganglia (0 of 18) yielded no virus. Also, ganglia that were latently infected with dlx3.1 were mock superinfected, and again no virus was recovered (0 of 6 DNA from mock-infected mice (Fig. 5) . The amount of viral DNA found in dlx0.7-infected ganglia was significantly less than that found in dlx3.1-infected ganglia and was 10-to 20-fold less than the amount found in KOS-infected ganglia. This was surprising since the level of dlx0.7 replication in eyes and ganglia during the acute stage of infection was roughly equivalent to that of dlx3.1. The reduced level of viral DNA in dlxO.7-infected ganglia relative to that in dlx3.1-infected ganglia was confirmed by superinfection assays in which less than one-half of the ganglia tested (5 of 12) yielded virus and significantly fewer plaques (mean of 1) were produced per ganglion (Table 1) . Once again, Southern blot analysis of viral DNA from reactivated plaque isolates revealed the presence of both mutant and wild-type ICPO alleles (Fig. 7) . As with the dlx3.1 mutant, no reactivation was demonstrated with dissociated dlx0.7-infected ganglia (0 of 6) in the absence of superinfection.
Taken together, these data indicate that ICPO plays a role in the, efficient establishment and reactivation of latency.
ICPO mutants can be reactivated under special conditions. Certain agents that affect gene expression such as the hypomethylating agent 5-azacytidine and dimethyl sulfoxide (DMSO) have been shown to increase the frequency of reactivation from ganglia latently infected with HSV-1 (46) . We therefore attempted to reactivate dlx0.7, dlx3.1, and n12 from latently infected ganglia by using these agents.
The addition of 50 ,uM 5-azacytidine to the medium of explant cultures failed to reactivate either dlx3.1 (0 of 8 ganglia) or dlx0.7 (0 of 8 ganglia) from latently infected (Fig. 3) . The truncated ICPO peptide has no detectable trans-activating activity in transient assays (40) . Despite the differences in the peptides that they encode and the ICP0 DNA sequences that they contain (Fig. 3) , the phenotypes of the three ICP0 mutants in cell culture are essentially the same (34, 40 shown the number of mice that were dead on day 30 postinfection relative to the total number of mice that were inoculated. The number of ganglia from which virus could be reactivated (in the absence of DMSO) on day 30 relative to the total number of ganglia tested for reactivation is presented as a fraction.
( Fig. 4 and 8) . Explant cultures at latently infected ganglia on day 30 postinfection, however, yielded virus in about onehalf of the ganglia tested (13 of 28; 46%) in the absence of DMSO or other special treatment. Tests for infectious d11403 virus on day 30 by homogenization and direct assay were negative (0 of 8 ganglia), demonstrating that virus recovered at this time following cocultivation is generated by reactivation. These results indicate that d11403 is less latency competent than its parent virus, strain 17, but is significantly more competent than either dlx3.1 or dlx0.7 in our latency model. DISCUSSION HSV-1 latency involves an ordered series of events which can be dissected by using mutants that are blocked at different stages in the process. In this study we attempted to identify the stages in the establishment and reactivation of ganglionic latency during which HSV-1 immediate-early proteins ICP4, ICPO, and ICP27 function. In previous studies of latency, viral reactivation alone has been used as a measure of latency competence. In this study we showed that the failure of virus to reactivate can be differentiated from its failure to establish latency in neurons.
Wild-type parameters of the mouse eye model. Prior to our testing of mutants in this system, a thorough investigation of HSV-1 strain KOS in the mouse eye model was undertaken in order to standardize this model for our purposes. The mouse eye model has been well documented in the literature for the investigation of HSV-1 latency (20, 37, 43) . Our studies of the behavior of wild-type strain KOS in the CD-1 mouse eye model demonstrated that this particular combination of model, virus, and mouse strain is an especially good one for studies of latency. The low neurovirulence of KOS permits us to use a spectrum of dosages with a reasonable guarantee that latency will be established in a high proportion of ganglia and that few animals will die. Our studies with KOS also confirmed the observation of Gordon and Rock (13) that the cocultivation assay is significantly more sensitive than DNA hybridization for the detection of latent virus in ganglia. Although the sensitivity of cocultivation assays can be enhanced by the addition of DMSO or other agents to culture media, the routine use of these agents can mask the reactivation-deficiency of certain viral mutants under normal cocultivation conditions.
Virus replication at the site of inoculation is important for the establishment of latency. The role of virus replication at the site of inoculation in the establishment of latency has been difficult to assess based on the results of previous studies using temperature-sensitive mutants (45) (42) and in this study (Fig. 4  and 8 ). To address this question we have begun to generate a XhoI to SalI deletion mutation in the ICP0 gene of KOS, a deletion identical to that found in d11403, so that we can assess strain-specific variables more directly.
A second explanation arises from differences in the sizes and locations of the deletions in ICP0 (Fig. 3) . Mutant dlx3.1 has a deletion of 2,965 base pairs from residues 1405 to 4370 of IRL (numbering system of Perry et al. [27] ), including the transcriptional start site, and should not express any of the ICP0 transcript or polypeptide, whereas dlx0.7 has a deletion of 798 base pairs from residues 2609 to 3407 of IRL and would specify a peptide which consists of the N-terminal 19 amino acids, which are specified by the first exon (Weizhong Cai, unpublished data). The 3' limit of the dlx0.7 deletion occurs in the second intron, such that the third exon is read out of frame. The d11403 mutant (from strain 17) has a deletion from residues 2939 to 5065 and could specify a polypeptide containing the N-terminal 105 amino acids specified by the first and part of the second exons; this is followed by the carboxy terminus of the third exon, which is out of frame (Fig. 3) . It is possible that the 86 amino acids specified by the undeleted portion of the second exon of d11403 are sufficient to render the mutant latency competent in vivo, even though this truncated peptide has no detectable activity in transient expression assays. By contrast, the 19 amino acids specified by the first exon of the dlx0.7 mutant are apparently not sufficient to give this mutant the ability to establish or reactivate from latency efficiently.
Of additional interest is the fact that the deletions in these three mutants differ in their positions relative to the recently mapped latency-associated transcript (LAT), which is abundant in the nuclei of latently infected ganglia of mice, rabbits, and humans (3, 32, 39, 44) . This transcript derives from the HSV-1 DNA strand opposite to that which encodes ICPO mRNA and partially overlaps the 3' end of the ICPO gene (Fig. 3) . Although LAT contains two open reading frames, no LAT-encoded protein has yet been demonstrated. In addition, a second less abundant RNA species, the so-called minor latency-related RNA, has been identified which overlaps the 5' end of the ICPO gene (32) . This transcript has yet to be fully characterized in terms of its position, size, direction of transcription, and sense.
Although ICPO is an efficient trans-activator of a variety of viral and cellular genes, it is dispensable for productive infection in cell culture (34, 40) . It has been suggested that a possible function of LAT is to suppress the expression of ICPO during latency by antisense repression, i.e., by RNA-RNA hybrid arrest of translation (39) . This model for the repression of viral gene expression predicts that HSV-1 mutants lacking ICPO would be reactivation deficient. The three ICPO deletion mutants tested were deficient to various degrees in their ability to reactivate. The only ICPO mutant tested whose deletion did not also delete the 3' end of LAT was dlx0.7, the mutant that was least able to establish and be reactivated from latency (Fig. 3) . The dlx3.1 mutant, which was slightly more latency competent than dlx0.7, may or may not contain the 3' end of LAT (up to 639 bases), although the extent of LAT sequences deleted cannot be ascertained until the 3' end of this transcript has been more finely mapped. Mutant d11403, which reactivated with the greatest frequency, lacks at least 1,040 bases of LAT, including the second potential open reading frame of LAT. Based on a comparison of the genotypes and phenotypes of the three ICPO mutants, it is tempting to speculate that the more LAT sequences removed in the absence of functional ICPO, the more latency competent the virus is, implying that the establishment and reactivation of latency involves the products (i.e., protein or RNA) of both the ICPO and LAT genes.
Possible roles of cellular factors in latency. The observation that DMSO could induce reactivation of dlx3.1 suggests that the block of reactivation of this mutant can be overcome by DMSO. The mode of action of DMSO is unknown, but it has been shown to have an effect on a number of cellular processes (4) , to induce recurrent disease in mice latently infected with HSV-1 (14) , and to increase the frequency of reactivation from ganglia latently infected with HSV-1 (46) . The inability of DMSO to induce the reactivation of dlx0.7 is probably caused by the inefficiency with which this mutant establishes latency, based on the low levels of viral DNA detected in ganglia. The precise mechanism by which DMSO induces reactivation of dlx3.1 warrants further investigation, with particular reference to the induction of specific viral and cellular genes by this agent.
Indeed, with regard to latency the study of viral factors
should not be considered in isolation from host cellular factors such as nerve growth factor (47) and prostaglandins (21) , which have been shown to affect the reactivation of HSV-1 from murine ganglia, presumably by perturbation of the physiology of the host cell. Further studies may show how such cellular factors interact with viral gene products such as ICPO and LAT and elucidate the molecular mechanisms by which HSV-1 can persist for the lifetime of its host. 
